Related Experiment Video
Updated: Apr 17, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Fontan-associated protein-losing enteropathy and plastic bronchitis
Kurt R Schumacher1, Kathleen A Stringer2, Janet E Donohue1
1University of Michigan Congenital Heart Center, C.S. Mott Children's Hospital, Ann Arbor, MI.
This study highlights patient-specific factors linked to Fontan-associated protein-losing enteropathy (PLE) and plastic bronchitis, revealing diverse, unpatterned treatment strategies for these rare conditions.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Gastroenterology
Background:
- Fontan-associated protein-losing enteropathy (PLE) and plastic bronchitis are rare, serious complications following the Fontan procedure.
- Current understanding of patient-specific factors and treatment patterns for these conditions is limited.
- Social media platforms offer a novel approach for recruiting participants in rare disease research.
Purpose of the Study:
- To characterize the medical history, disease progression, and treatment of current-era patients with Fontan-associated protein-losing enteropathy (PLE) and plastic bronchitis.
- To identify patient-specific factors associated with the development of PLE and plastic bronchitis post-Fontan procedure.
Main Methods:
- A novel online survey was distributed via a Facebook portal to recruit participants, leveraging social media for study recruitment.
- The survey collected data on demographics, medical history, and treatment information from patients with and without PLE or plastic bronchitis.
- Case control analyses compared patients with PLE and plastic bronchitis to uncomplicated control patients who underwent the Fontan procedure.
Main Results:
- The survey included 671 subjects: 76 with PLE, 46 with plastic bronchitis, and 7 with both.
- Patients with PLE showed higher incidences of hypoplastic left ventricle, chylothorax, and additional cardiothoracic surgery compared to controls.
- Patients with plastic bronchitis had increased rates of chylothorax and seasonal allergies compared to controls.
Conclusions:
- Patient-specific factors are significantly associated with the development of Fontan-associated protein-losing enteropathy and plastic bronchitis.
- Treatment strategies for these conditions are highly diverse and lack clear, consistent patterns.
- Further research is needed to establish consensus-based treatment approaches and design future therapeutic studies for these rare complications.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Pancreatitis II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

